Hemas Holdings PLC (HHL) - 4Q FY25

Unlock Exclusive Access!

Access exclusive content available only to registered members. Register or Login to experience exclusive insights and benefits.

Earnings Reviews
04/06/2025
228
0
HHL reported an EPS of LKR 0.90 for 4Q FY25, along with the PATMI growth of 63.6% YoY to LKR 2.6bn. Group topline witnessed a marginal drop of 3.5% YoY to LKR 30.3bn owing to the decline stemming from Consumer Brands. EBIT margins, however, strengthened to 10.5% (from previous 9.5%) supported by operational efficiencies and favourable macro conditions. We believe HHL’s strong positioning in the Healthcare and Consumer Brands verticals will continue to drive earnings growth.
Discussion (0)
Latest Reports